NYSE:SCA

Stellus Capital Investment 5.75 % Notes 2017-15.09.22 Stock News

etoro logo Buy SCA
*Your capital is at risk
$25.07
-0.620 (-2.41%)
At Close: Jun 05, 2026
Svenska Cellulosa Aktiebolaget SCA (publ) (SCABY) Q4 2025 Earnings Call Transcript
/PRNewswire/ -- IBS Software today announced a multi-year Strategic Collaboration Agreement (SCA) with Amazon Web Services (AWS) to accelerate the
Svenska Cellulosa Aktiebolaget SCA (publ) (OTCPK:SCABY) Q3 2025 Earnings Call October 24, 2025 4:00 AM EDT Company Participants Anders Edholm - Senior Vice President of Sustainability & Communications
Paris, August 12, 2025 5:45 p.m. YOUR LEASING SOLUTION FOR SUSTAINABLE TRANSPORT Effective transfer of TOUAX SCA shares to Euronext Growth® Paris and delisting from the regulated market of Euronext P
PRESS RELEASE        Paris, June 12, 2025 5:45 PM YOUR LEASING SOLUTION FOR SUSTAINABLE TRANSPORT TOUAX SCA's Combined General Meeting of Shareholders approves the proposed transfer of listing
REGULATED INFORMATION        Paris, May 7, 2025 5:45 PM YOUR LEASING SOLUTION FOR SUSTAINABLE TRANSPORT Proposal to transfer the listing of TOUAX shares from the Euronext Paris market to the E
BURLINGTON, Mass. , March 6, 2025 /PRNewswire/ -- Black Duck® Software, Inc. ("Black Duck"), a leading provider of application security solutions, today announced that STMicroelectronics (NYSE:ST
Spinocerebellar Ataxia (SCA) is a rare, genetic, life-threatening neurodegenerative disease with no available treatment. Troriluzole demonstrated a 50-70% slowing of SCA disease progression on the pri
BHV-1300 achieved deep lowering of targeted IgG, with reductions > 60% in the lowest subcutaneous dose tested in the MAD. Subcutaneous BHV-1300 achieved rapid and progressive lowering of IgG within h
Biohaven's pipeline progression includes Troriluzole for spinocerebellar ataxia [SCA], which has shown a 50-70% reduction in disease progression over three years. BHV-2100, a non-opioid migraine treat
Biohaven Ltd. reported positive results from a pivotal study using troriluzole for the treatment of patients with spinocerebellar ataxia; the Drug achieved 50% to 70% of slowing of disease progression
Troriluzole 200 mg dosed orally, once daily, in patients with SCA met the study's primary endpoint on the change from baseline in the modified functional Scale for the Assessment and Rating of Ataxia
Acquisition accelerates Abacus' expansion as a global alternative asset manager and origination company Deal will add up to $2 billion in AUM to Abacus ORLANDO, Fla., July 18, 2024 (GLOBE NEWSWIRE) --
Pursuant to LVMH's liquidity contract with Oddo BHF SCA, on the 30th of June 2024 the following amounts appeared on the liquidity account.
Press Release VELIZY-VILLACOUBLAY, France — July 2, 2024 Half-year statement of the Liquidity contract entered into with Oddo BHF SCA Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) announ
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE